FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - BOERSE MUENCHEN 19:26:37 24/05/2024 BST | ||
| 11.07 EUR | -3.32% |
|
| Current month | -0.54% | ||
| 1 month | +2.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 11.07 | -3.32% |
| 23/05/24 | 11.45 | -3.38% |
| 22/05/24 | 11.85 | -2.31% |
| 21/05/24 | 12.13 | -5.46% |
| 20/05/24 | 12.83 | +5.86% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 07:26 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG3BLX |
| ISIN | DE000GG3BLX6 |
| Date issued | 01/02/2024 |
| Strike | 113.5 $ |
| Maturity | Unlimited |
| Parity | 2.46 : 1 |
| Emission price | 8.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.83 € |
|---|---|
| Lowest since issue | 6.88 € |
| Spread | 0.3 € |
| Spread % | 2.63% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.3
USD
Average target price
146.8
USD
Spread / Average Target
+3.91%
- Stock Market
- Certificates
- Certificat
